A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Filamon LTD
Neonc Technologies, Inc.
National Cancer Institute (NCI)
Essen Biotech
Essen Biotech
xCures
Swansea Bay University Health Board
Orano Med LLC
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Mayo Clinic
GlaxoSmithKline
Novartis
Incyte Corporation
AVM Biotechnology Inc
LigaChem Biosciences, Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Apollomics Inc.
Eli Lilly and Company
Bayer
Shandong Cancer Hospital and Institute
Stanford University
Cedars-Sinai Medical Center
BerGenBio ASA
Blueprint Medicines Corporation
University Hospital, Antwerp
ABM Therapeutics Corporation
NGM Biopharmaceuticals, Inc
ABM Therapeutics Corporation
Cedars-Sinai Medical Center
Celgene
Novo Nordisk A/S
Sumitomo Pharma America, Inc.
SCRI Development Innovations, LLC
Karyopharm Therapeutics Inc
Quadriga Biosciences, Inc.
Celgene
Fudan University
Gilead Sciences
Hospices Civils de Lyon
SpeciCare
Jiujiang University Affiliated Hospital
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
Celldex Therapeutics
Stanford University
Icahn School of Medicine at Mount Sinai